The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8999957, Table 2, Compound 57 ID: ALA3654532
Chembl Id: CHEMBL3654532
PubChem CID: 89509118
Max Phase: Preclinical
Molecular Formula: C25H27N5O2S
Molecular Weight: 461.59
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccsc1CN1CCC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)C1
Standard InChI: InChI=1S/C25H27N5O2S/c1-16-12-17(7-9-26-16)24-20-13-18(5-6-21(20)28-29-24)25(31)27-19-4-3-10-30(14-19)15-23-22(32-2)8-11-33-23/h5-9,11-13,19H,3-4,10,14-15H2,1-2H3,(H,27,31)(H,28,29)/t19-/m1/s1
Standard InChI Key: IRFBMLPFMDMXKG-LJQANCHMSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 461.59Molecular Weight (Monoisotopic): 461.1885AlogP: 4.40#Rotatable Bonds: 6Polar Surface Area: 83.14Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.21CX Basic pKa: 7.20CX LogP: 3.28CX LogD: 3.07Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.44Np Likeness Score: -1.70
References 1. (2015) Heterocyclic compounds as ERK inhibitors,